[Form 4] GE HealthCare Technologies Inc. Insider Trading Activity
GE HealthCare Technologies insider transaction: Kenneth R. Stacherski, Chief Enterprise Operating Officer, reported two disposals of GEHC common stock on 09/01/2025. The filings show 458 shares and 434 shares were disposed of at a price of $73.73 per share, resulting in 41,430 and 40,996 shares beneficially owned after each reported transaction.
The form states these disposals represent withholding of shares to satisfy tax withholding obligations in connection with the vesting of restricted stock units. The Form 4 was signed by the company’s General Counsel as attorney-in-fact on 09/03/2025.
Operazione interna di GE HealthCare Technologies: Kenneth R. Stacherski, Chief Enterprise Operating Officer, ha dichiarato due cessioni di azioni ordinarie GEHC in data 01/09/2025. I documenti indicano che sono state cedute 458 azioni e 434 azioni al prezzo di $73,73 per azione, con un conseguente possesso effettivo di 41.430 e 40.996 azioni dopo ciascuna delle operazioni riportate.
Il modulo specifica che queste cessioni rappresentano la ritenuta di azioni per soddisfare gli obblighi di pagamento delle imposte connessi al maturare di restricted stock units. Il Modulo 4 è stato firmato dall’Avvocato Generale della società in qualità di procuratore il 03/09/2025.
Transacción de un insider de GE HealthCare Technologies: Kenneth R. Stacherski, Chief Enterprise Operating Officer, informó dos disposiciones de acciones ordinarias de GEHC el 01/09/2025. Los registros muestran que se dispusieron 458 acciones y 434 acciones a un precio de $73.73 por acción, resultando en 41.430 y 40.996 acciones en propiedad beneficiosa tras cada transacción reportada.
El formulario indica que estas disposiciones representan la retención de acciones para cumplir con las obligaciones de retención de impuestos en relación con la consolidación de restricted stock units. El Formulario 4 fue firmado por el Asesor General de la compañía como apoderado el 03/09/2025.
GE HealthCare Technologies 내부자 거래: 최고 엔터프라이즈 운영책임자(Chief Enterprise Operating Officer) Kenneth R. Stacherski는 2025-09-01에 GEHC 보통주 2건의 처분을 신고했습니다. 제출 서류에 따르면 각각 458주와 434주가 주당 $73.73에 처분되었으며, 각 신고 거래 후 보유 유익지분은 각각 41,430주와 40,996주로 나타났습니다.
해당 양식은 이 처분들이 제한주식단위(restricted stock units)의 취득과 관련된 세금 원천징수 의무를 충족하기 위해 주식을 원천징수한 것임을 명시하고 있습니다. Form 4는 회사 법무담당이 대리인으로서 2025-09-03에 서명했습니다.
Transaction d'initié de GE HealthCare Technologies : Kenneth R. Stacherski, Chief Enterprise Operating Officer, a déclaré deux cessions d'actions ordinaires GEHC le 01/09/2025. Les documents indiquent que 458 actions et 434 actions ont été cédées au prix de 73,73 $ par action, entraînant une propriété bénéficiaire de 41 430 et 40 996 actions après chacune des transactions déclarées.
Le formulaire précise que ces cessions correspondent à la retenue d'actions afin de satisfaire les obligations de retenue fiscale liées à l'acquisition de restricted stock units. Le formulaire 4 a été signé par le General Counsel de la société en tant que mandataire le 03/09/2025.
Insider-Transaktion von GE HealthCare Technologies: Kenneth R. Stacherski, Chief Enterprise Operating Officer, meldete am 01.09.2025 zwei Veräußerungen von GEHC-Stammaktien. Aus den Unterlagen geht hervor, dass 458 und 434 Aktien zu je $73,73 veräußert wurden, wodurch sich nach den jeweiligen gemeldeten Transaktionen ein wirtschaftlicher Besitz von 41.430 bzw. 40.996 Aktien ergibt.
Das Formular gibt an, dass diese Veräußerungen die Einbehaltung von Aktien zur Erfüllung von Steuerabzugsverpflichtungen im Zusammenhang mit dem Vesting von Restricted Stock Units darstellen. Das Formular 4 wurde am 03.09.2025 vom General Counsel des Unternehmens als Bevollmächtigtem unterzeichnet.
- None.
- None.
Insights
TL;DR Routine insider tax-withholding sales tied to RSU vesting, not a consultative market signal.
The reported transactions are labeled as disposals due to withholding to satisfy tax obligations on vesting restricted stock units. Transaction codes (F) indicate disposition by other means, consistent with share-withholding for taxes rather than open-market sales to raise cash. The sizes—458 and 434 shares at $73.73—are small relative to total holdings of ~41,000 shares, implying limited direct impact on float or valuation.
TL;DR Administrative compliance filing showing standard RSU withholding; no governance red flags apparent.
The Form 4 discloses routine compliance with Section 16 reporting requirements. The use of an attorney-in-fact signature and explicit explanation that shares were withheld for tax withholding are normal. There is no indication of unusual timing, related-party transactions, or departures from typical equity compensation administration in the filing.
Operazione interna di GE HealthCare Technologies: Kenneth R. Stacherski, Chief Enterprise Operating Officer, ha dichiarato due cessioni di azioni ordinarie GEHC in data 01/09/2025. I documenti indicano che sono state cedute 458 azioni e 434 azioni al prezzo di $73,73 per azione, con un conseguente possesso effettivo di 41.430 e 40.996 azioni dopo ciascuna delle operazioni riportate.
Il modulo specifica che queste cessioni rappresentano la ritenuta di azioni per soddisfare gli obblighi di pagamento delle imposte connessi al maturare di restricted stock units. Il Modulo 4 è stato firmato dall’Avvocato Generale della società in qualità di procuratore il 03/09/2025.
Transacción de un insider de GE HealthCare Technologies: Kenneth R. Stacherski, Chief Enterprise Operating Officer, informó dos disposiciones de acciones ordinarias de GEHC el 01/09/2025. Los registros muestran que se dispusieron 458 acciones y 434 acciones a un precio de $73.73 por acción, resultando en 41.430 y 40.996 acciones en propiedad beneficiosa tras cada transacción reportada.
El formulario indica que estas disposiciones representan la retención de acciones para cumplir con las obligaciones de retención de impuestos en relación con la consolidación de restricted stock units. El Formulario 4 fue firmado por el Asesor General de la compañía como apoderado el 03/09/2025.
GE HealthCare Technologies 내부자 거래: 최고 엔터프라이즈 운영책임자(Chief Enterprise Operating Officer) Kenneth R. Stacherski는 2025-09-01에 GEHC 보통주 2건의 처분을 신고했습니다. 제출 서류에 따르면 각각 458주와 434주가 주당 $73.73에 처분되었으며, 각 신고 거래 후 보유 유익지분은 각각 41,430주와 40,996주로 나타났습니다.
해당 양식은 이 처분들이 제한주식단위(restricted stock units)의 취득과 관련된 세금 원천징수 의무를 충족하기 위해 주식을 원천징수한 것임을 명시하고 있습니다. Form 4는 회사 법무담당이 대리인으로서 2025-09-03에 서명했습니다.
Transaction d'initié de GE HealthCare Technologies : Kenneth R. Stacherski, Chief Enterprise Operating Officer, a déclaré deux cessions d'actions ordinaires GEHC le 01/09/2025. Les documents indiquent que 458 actions et 434 actions ont été cédées au prix de 73,73 $ par action, entraînant une propriété bénéficiaire de 41 430 et 40 996 actions après chacune des transactions déclarées.
Le formulaire précise que ces cessions correspondent à la retenue d'actions afin de satisfaire les obligations de retenue fiscale liées à l'acquisition de restricted stock units. Le formulaire 4 a été signé par le General Counsel de la société en tant que mandataire le 03/09/2025.
Insider-Transaktion von GE HealthCare Technologies: Kenneth R. Stacherski, Chief Enterprise Operating Officer, meldete am 01.09.2025 zwei Veräußerungen von GEHC-Stammaktien. Aus den Unterlagen geht hervor, dass 458 und 434 Aktien zu je $73,73 veräußert wurden, wodurch sich nach den jeweiligen gemeldeten Transaktionen ein wirtschaftlicher Besitz von 41.430 bzw. 40.996 Aktien ergibt.
Das Formular gibt an, dass diese Veräußerungen die Einbehaltung von Aktien zur Erfüllung von Steuerabzugsverpflichtungen im Zusammenhang mit dem Vesting von Restricted Stock Units darstellen. Das Formular 4 wurde am 03.09.2025 vom General Counsel des Unternehmens als Bevollmächtigtem unterzeichnet.